Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 76.07

+0.9%

Nov 12 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: arnold silver who wrote (174)	1/7/2003 9:31:41 PM
From: JMarcus	Read Replies (2) of 3722

<<I can't even find a reason for the name change.>> The company is trying to distance itself from its SNAFU in trying to develop its once-flagship molecule, Neotrofin, for Alzheimers. News about that shady history isn't on SPPI's website, but you can find it on the old SI thread for NEOT. The announcement of Neotrofin's final demise is posted there: Message 17423517 The new focus of the company is cancer therapeutics. At least one biofreak thinks the new management may have a chance at turning the company around: siliconinvestor.com I lost a bundle on NEOT, so I'm gunshy, even though SPPI really is a completely new company. Marc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next